From the Second Department of Internal Medicine, Faculty of Medicine,
Kyushu University, Fukuoka, Japan.
Correspondence to Shuntaro Kagiyama, MD, Second Department of Internal Medicine, Faculty of Medicine, Kyushu University, Maidashi 31-1, Higashi-ku, Fukuoka 8128582, Japan. E-mail kagiyama{at}intmed2.med.kyushu-u.ac.jp
AbstractPossible impairment of the
L-argininenitric oxide (NO) pathway in the rostral
ventrolateral medulla of adult spontaneously hypertensive rats (SHR)
was investigated by microinjecting
NG-nitro-L-arginine methyl ester
(L-NAME), NOC 18 (an NO donor), or L-arginine. Unilateral
injection of L-NAME (10 nmol/50 nL) into the rostral ventrolateral
medulla significantly increased mean arterial pressure
(MAP) in both SHR and Wistar-Kyoto rats (WKY). The increases in MAP did
not differ significantly between the two strains (15±3 versus
10±2 mm Hg, respectively; n=8). In contrast, microinjection of
L-arginine elicited significant (P<.05)
dose-dependent decreases in MAP in both strains, and these depressor
responses were significantly greater in SHR than in WKY (in 10 nmol of
L-arginine: 29±2 versus 15±2 mm Hg,
respectively; n=8, P<.01). Similarly, microinjection of
NOC 18 (10 nmol/50 nL) reduced MAP in both strains, and the depressor
response was also significantly greater in SHR than in WKY (38±7
versus 22±3 mm Hg, respectively; n=8, P<.05).
These results suggest that the L-arginineNO pathway in
the rostral ventrolateral medulla is impaired in SHR and that this
impairment may contribute to the increase in arterial
pressure in this animal model of genetic hypertension.
© 1998 American Heart Association, Inc.
Scientific Contributions
Enhanced Depressor Response to Nitric Oxide in the Rostral Ventrolateral Medulla of Spontaneously Hypertensive Rats
Key Words: L-arginine NOC 18 L-NAME medulla oblongata microinjection
This article has been cited by other articles:
![]() |
L.-C. Kung, S. H. H. Chan, K. L. H. Wu, C.-C. Ou, M.-H. Tai, and J. Y. H. Chan Mitochondrial Respiratory Enzyme Complexes in Rostral Ventrolateral Medulla as Cellular Targets of Nitric Oxide and Superoxide Interaction in the Antagonism of Antihypertensive Action of eNOS Transgene Mol. Pharmacol., November 1, 2008; 74(5): 1319 - 1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kimura, Y. Hirooka, Y. Sagara, K. Ito, T. Kishi, H. Shimokawa, A. Takeshita, and K. Sunagawa Overexpression of Inducible Nitric Oxide Synthase in Rostral Ventrolateral Medulla Causes Hypertension and Sympathoexcitation via an Increase in Oxidative Stress Circ. Res., February 4, 2005; 96(2): 252 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kishi, Y. Hirooka, K. Ito, K. Sakai, H. Shimokawa, and A. Takeshita Cardiovascular Effects of Overexpression of Endothelial Nitric Oxide Synthase in the Rostral Ventrolateral Medulla in Stroke-Prone Spontaneously Hypertensive Rats Hypertension, February 1, 2002; 39(2): 264 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zanzinger Role of nitric oxide in the neural control of cardiovascular function Cardiovasc Res, August 15, 1999; 43(3): 639 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sander, B. Chavoshan, and R. G. Victor A Large Blood Pressure–Raising Effect of Nitric Oxide Synthase Inhibition in Humans Hypertension, April 1, 1999; 33(4): 937 - 942. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |